India's Sun Pharma buys troubled rival Ranbaxy for $3.2 bn (Update)
India's third-biggest drugs company Sun Pharma announced Monday a $3.2-billion deal to buy larger domestic rival Ranbaxy from Daiichi Sankyo, ending the Japanese company's costly run as owner.
Apr 7, 2014
0
0